Tecnis Symfony OptiBlue Lens for Cataracts
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new lens implant for people with cataracts, particularly those with additional eye conditions like retinal issues. The lens, Tecnis Symfony OptiBlue, aims to enhance vision at all distances and reduce visual disturbances by filtering specific light wavelengths. Ideal candidates have cataracts and retinal comorbidities, seek improved vision, and have not undergone previous eye surgeries. As an unphased trial, this study provides an opportunity to advance eye care solutions for complex conditions.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Tecnis Symfony OptiBlue Lens is safe for cataract patients?
Research has shown that the Tecnis Symfony OptiBlue Intraocular Lens (IOL) is generally well-received by patients in previous studies. Users of this lens reported good results with few visual issues. Studies indicate that the lens enhances vision by blocking certain types of light, greatly improving clarity and comfort.
Additionally, comparisons of the Tecnis Symfony lens family, including the OptiBlue version, with other standard lenses have found it to be just as safe and often better for vision at middle distances. This means it helps people see clearly at various distances and is safe for use.
Overall, this lens has been tested in many trials and has a strong safety record. While this study phase does not provide new safety data, the lens's history in other studies and its ability to improve vision with minimal side effects make it a promising choice for those considering cataract surgery.12345Why are researchers excited about this trial?
The Tecnis Symfony OptiBlue Lens is unique because it offers an extended depth of focus (EDOF) for those with cataracts, unlike traditional monofocal lenses that only improve vision at a single distance. This lens features a special OptiBlue filter, which enhances contrast by reducing glare and halos, common issues with existing multifocal lenses. Researchers are excited about this treatment because it promises to improve both near and distance vision with fewer visual disturbances, potentially offering a more seamless visual experience for cataract patients.
What evidence suggests that the Tecnis Symfony OptiBlue Lens is effective for cataracts?
Research has shown that the Tecnis Symfony OptiBlue Intraocular Lens (IOL), which participants in this trial will receive, greatly improves vision after cataract surgery. Patients often notice enhanced vision for distant objects and tasks at arm's length, such as reading a computer screen. Compared to regular lenses, the Symfony IOL reduces the need for glasses at various distances. Some patients have reported seeing halos (rings of light) around lights, but many find their overall vision quality excellent. Previous studies suggest that this lens offers a good balance of clear vision at different distances.15678
Are You a Good Fit for This Trial?
This trial is for individuals undergoing cataract surgery who wish to improve their vision at various distances. It's specifically testing a new type of lens implant that filters certain light wavelengths. Patients with additional eye conditions affecting the retina may also participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo femtosecond laser-assisted cataract surgery with implantation of the Tecnis Symfony OptiBlue/ Tecnis Symfony OptiBlue toric IOL in both eyes
Follow-up
Participants are monitored for visual outcomes at distance, intermediate, and near following cataract surgery and implantation of Tecnis Symfony Optiblue IOL
What Are the Treatments Tested in This Trial?
Interventions
- Tecnis Symfony OptiBlue EDOF Intraocular Lens
Find a Clinic Near You
Who Is Running the Clinical Trial?
Coastal Eye Surgeons PLLC
Lead Sponsor